Allografted Recipients Immunized Against Hepatitis B Virus are at High Risk of Gradual Surface Antibody (HbsAb) Disappearance Post Transplant, Regardless of Adoptive Immunity Transfer

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 9, 2007, Pages 1049-1056

  Kaloyannidis, Panayotis ^a   Batsis, Ioannis ^a   Yannaki, Evangelia ^a   Adamidou, Despina ^a   Bartzoudis, Dimitrios ^a   Papathanasiou, Maria ^a   Mallouri, Despina ^a   Sakellari, Ioanna ^a   Fassas, Athanasios ^a   Anagnostopoulos, Achilles ^a  

^a G PAPANICOLAOU HOSPITAL   (Greece)

Author keywords

Adoptive immunity transfer; Allogeneic stem cell transplantation; HbsAb; Hepatitis B virus

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIBODY TITER; ARTICLE; BLOOD DONOR; CELLULAR IMMUNITY; CHRONIC GRAFT VERSUS HOST DISEASE; ERADICATION THERAPY; FEMALE; GRAFT RECIPIENT; HEMATOLOGIC DISEASE; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK PATIENT; HUMAN; HUMAN CELL; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PROBABILITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNOTHERAPY, ACTIVE; IMMUNOTHERAPY, ADOPTIVE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE;

EID: 34547667076     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.05.009     Document Type: Article

References (33)

1. Kane M. Global programme for control of hepatitis B infection. Vaccine 13 Suppl 1 (1995) S47-S49
2. Hui C.K., Lie A., Au W.Y., et al. A long-term follow-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation. Blood 106 (2005) 464-469
3. Ozdogan O., Ratip S., Ahdab Y.A., et al. Causes and risk factors for liver injury following bone marrow transplantation. J Clin Gastroenterol 36 (2003) 421-426
4. Storek J., and Witherspoon R.P. Immunologic reconstitution after hematopoietic stem cell transplantation. In: Atkinson K. (Ed). Clinical Bone Marrow and Blood Stem Cell Transplantation (2000), University Press, Cambridge, UK 111-146
5. Auletta J.J., and Lazarus H.M. Immune restoration following hematopoietic stem cell transplantation: an evolving target. Bone Marrow Transplant 35 (2005) 835-857
6. Abrahamsen I.W., Somme S., Heldal D., Egeland T., Kvale D., and Tjonnfjord G.E. Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease. Haematologica 90 (2005) 86-93
7. Ochs L., Shu X.O., Miller J., et al. Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. Blood 86 (1995) 3979-3986
8. Ilan Y., Nagler A., Adler R., et al. Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation. Hepatology 18 (1993) 246-252
9. Lindemann M., Barsegian V., Runde V., et al. Transfer of humoral and cellular hepatitis B immunity by allogeneic hematopoietic cell transplantation. Transplantation 75 (2003) 833-838
10. Idilman R., Ustun C., Karayalcin S., et al. Hepatitis B virus vaccination of recipients and donors of allogeneic peripheral blood stem cell transplantation. Clin Transplant 17 (2003) 438-443
11. Ljungman P., Engelhard D., de la Camara R., et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 35 (2005) 737-746
12. Lau G.K., Lok A.S., Liang R.H., et al. Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer. Hepatology 25 (1997) 1497-1501
13. Lau G.K., Suri D., Liang R., et al. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology 122 (2002) 614-624
14. Brugger S.A., Oesterreicher C., Hofmann H., Kalhs P., Greinix H.T., and Muller C. Hepatitis B virus clearance by transplantation of bone marrow from hepatitis B immunised donor. Lancet 349 (1997) 996-997
15. Chen P.M., Fan S., Liu C.J., et al. Changing of hepatitis B virus markers in patients with bone marrow transplantation. Transplantation 49 (1990) 708-713
16. Onozawa M., Hashino S., Izumiyama K., et al. Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection. Transplantation 79 (2005) 616-619
17. Goyama S., Kanda Y., Nannya Y., et al. Reverse seroconversion of hepatitis B virus after hematopoietic stem cell transplantation. Leuk Lymphoma 43 (2002) 2159-2163
18. Dhedin N., Douvin C., Kuentz M., et al. Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc. Transplantation 66 (1998) 616-619
19. Knoll A., Boehm S., Hahn J., Holler E., and Jilg W. Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 33 (2004) 925-929
20. Hui C.K., and Lau G.K. Immune system and hepatitis B virus infection. J Clin Virol 34 Suppl 1 (2005) S44-S48
21. Crooks G.M., Weinberg K., and Mackall C. Immune reconstitution: from stem cells to lymphocytes. Biol Blood Marrow Transplant 12 Suppl 1 (2006) 42-46
22. van Tol M.J., Gerritsen E.J., de Lange G.G., et al. The origin of IgG production and homogeneous IgG components after allogeneic bone marrow transplantation. Blood 87 (1996) 818-826
23. Storek J., Dawson M.A., Storer B., et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 97 (2001) 3380-3389
24. Ottinger H.D., Beelen D.W., Scheulen B., Schaefer U.W., and Grosse-Wilde H. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 88 (1996) 2775-2779
25. Chen B.J., Cui X., Sempowski G.D., Domen J., and Chao N.J. Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation. Blood 103 (2004) 4344-4352
26. Handgretinger R., Klingebiel T., Lang P., et al. Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant 27 (2001) 777-783
27. Weinberg K., Blazar B.R., Wagner J.E., et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 97 (2001) 1458-1466
28. Hakim F.T., Memon S.A., Cepeda R., et al. Age-dependent incidence, time course, and consequences of thymic renewal in adults. J Clin Invest 115 (2005) 930-939
29. Zand M.S., Vo T., Huggins J., Felgar R., et al. Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways. Transplantation 79 (2005) 1507-1515
30. Lau G.K., Liang R., Lee C.K., and Lim W.L. Is vaccination of donor adequate for clearance of hepatitis B virus after bone-marrow transplantation?. Lancet 349 (1997) 1626-1627
31. Lau G.K., Liang R., Lee C.K., et al. Clearance of persistent hepatitis B virus infection in Chinese bone marrow transplant recipients whose donors were anti-hepatitis B core- and anti-hepatitis B surface antibody-positive. J Infect Dis 178 (1998) 1585-1591
32. Seth P., Alrajhi A.A., Kagevi I., et al. Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease. Bone Marrow Transplant 30 (2002) 189-194
33. Rehermann B., Ferrari C., Pasquinelli C., and Chisari F.V. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 2 (1996) 1104-1108